An enzyme activity splitting FAD to AMP and riboflavin 4h,5h-cyclic phosphate (4h,5h-cFMN), with a K m of 6-8 µM, was partially purified from the cytosolic fraction of rat liver homogenates. 4h,5h-cFMN was characterized by enzyme, HPLC, UV-visible and NMR spectroscopic analyses. The data suggest that a novel enzyme, tentatively named FAD-AMP lyase
INTRODUCTION
The common forms of riboflavin or vitamin B # in animals are FMN and FAD (prosthetic groups of many oxidoreductases [1, 2] ) formed from riboflavin in two steps catalysed by flavokinase [3] [4] [5] [6] and FAD synthetase [6] [7] [8] ). The intracellular fate of flavin nucleotides in mammals is the flavinylation of apoenzymes [9, 10] and little intracellular FMN and FAD is found in the free state : less than 0n05 µM and about 1 µM respectively in mammalian liver [6] . The catabolism of flavocoenzymes is believed to depend on phosphohydrolases, FAD pyrophosphatase [11] [12] [13] [14] [15] and FMN phosphomonoesterase [14] [15] [16] [17] , which either act at extracellular surfaces as part of vitamin B # -uptake pathways or are linked to (trapped in) intracellular membranes.
During a search for FAD-splitting enzymes in rat liver, we found a Mn# + -dependent activity which was partially purified from the cytosolic fraction of rat liver homogenates and was shown to produce AMP and riboflavin 4h,5h-cyclic phosphate (4h,5h-cFMN). Both the enzyme, tentatively named FMN cyclase, and its cyclic flavin product were previously unknown in biological materials.
MATERIALS AND METHODS

Materials
Female Wistar rats weighing around 200 g were used. FAD was from Sigma and MnCl # from Merck. Other (di)nucleotides and nucleosides were from standard commercial suppliers. Snake venom phosphodiesterase and alkaline phosphatase were from Boehringer (cat. no. 108260 and 108146 respectively). Rat liver nucleotide pyrophosphatase was purified by a shortened version of a published procedure [18] . In short, it was extracted from rat liver membranes with Triton X-100, solubilized by limited trypsin treatment, adsorbed on a DEAE-cellulose column in buffer G (20 mM Tris\HCl, pH 8n7, 5 mM MgCl # ), recovered with a 0-400 mM NaCl linear gradient in buffer G, concentrated by ultrafiltration through a PM30 membrane (Amicon), chromatographed on a Sephacryl S-200 column in buffer G, concentrated Abbreviations used : cFMN, riboflavin cyclic phosphate ; DEPT, distortionless enhancement by polarization transfer. 1 R.M.P., M.J.C., J.C. and J.C.C. dedicate this paper to their teachers, Antonio Sillero and Mari ! a Antonia Gu$ nther Sillero. 2 To whom correspondence should be addressed.
(cyclizing) or FMN cyclase, is involved. Also, 4h,5h-cFMN was hydrolysed to 5h-FMN by a rat liver cyclic phosphodiesterase. The results indicate a novel enzymic pathway for flavins in mammals, and support the biological relevance of 4h,5h-cFMN, perhaps as a flavocoenzyme or a regulatory signal.
again, and buffer-exchanged to 5 mM sodium phosphate, pH 8n25, on a Sephadex G-25 column (PD10 ; Pharmacia). The specific activity, with p-nitrophenyl-dTMP as substrate, was 13 units\mg. It was supplemented with 1 mg\ml BSA and kept at k20 mC.
Partial purification of FMN cyclase activity
The crude extract was the cytosolic fraction, i.e. the 100 000 g supernatant of an isotonic rat liver homogenate in 3 vol. of 20 mM Tris\HCl, pH 7n5, containing 0n5 mM EDTA, 0n25 M sucrose and 1n3 mM PMSF. The 30-60 %-satd (NH % ) # SO % fraction was filtered through a Sephadex G-100 column (119 cmi2cm) ( Figure 1A ), followed by negative adsorption chromatography through an in-series set of columns ( Figure 1B ) composed of DEAE-cellulose DE-52 (44 cmi1n8 cm), Reactive Blue 2-Sepharose CL6B (5n5 cmi1n5 cm), Reactive Brown 10-agarose (3n2 cmi1n7 cm) and Reactive Blue 4-agarose (3n3 cmi1n7 cm), all equilibrated in and eluted with buffer T (20 mM Tris\HCl, pH 7n5, 0n5 mM EDTA) except for the DEAEcellulose, which was equilibrated without EDTA, but eluted with buffer T as part of the in-series set. The active flow through fractions were adsorbed on a Reactive Green 19-agarose column (6n0 cmi1n5 cm) in buffer T. The activity was eluted with a 250 ml KCl gradient (0-200 mM KCl) in buffer T ( Figure 1C ). This yielded partially purified enzyme (SDS\PAGE results not shown), enriched 40-fold with a yield of 16 % (Table 1) , and stable for at least 1 month at 4 mC. Protein was assayed by the method of Bradford [19] .
Enzyme assays
FMN cyclase activity was routinely assayed measuring colorimetrically the P i liberated from the product AMP in 50 mM Tris\HCl, pH 7n5, containing 6 mM MnCl # , 1n2 mM FAD, 1 mg\ml BSA and 7n5 unit\ml alkaline phosphatase. In the assays carried out to investigate the possible activity of FMN cyclase on NAD + , NADH or diadenosine 5h,5e-diphosphate, the composition of the reaction mixtures was the same except for the substitution of one of these compounds for FAD. Samples were The data correspond to a purification started from 32 g of fresh rat liver. Details of purification and activity assay (by the standard P i -release assay) are given in the Materials and methods section. taken at 1-10 min intervals, quenched with 10 vol. of a P i reagent (6 vol. of 3n4 mM ammonium molybdate in 0n5 M H # SO % , 1 vol. of 570 mM ascorbic acid, 0n37 vol. of 350 mM SDS), and A #)! was measured after 20 min at 45 mC. At FAD concentrations below 50 µM ( Figure 2C ), the linear A #'& increase due to the hyperchromicity of FAD splitting (ε l 7200 M −" :cm −" ) was recorded in the absence of alkaline phosphatase. To validate the P i -release and hyperchromicity assays, enzyme activity was also assayed by measuring the rate of 4h,5h-cFMN accumulation by HPLC method 4 (see below), which afforded the rapid separation of FAD and cFMN (retention times 3n5 and 4n5 min respectively) and their quantification with detection at 430 nm (ε 9600 and 11300 M −" :cm −" respectively). In all cases, to correct for nonenzymic FAD splitting, every individual assay was run strictly in parallel with a control in which enzyme buffer was substituted for enzyme sample. Blanks without substrate were also run and subtracted as required. The rates measured in mixtures with enzyme less that of no-enzyme controls were proportional to protein concentration (for example, see Figure 2A ). Taking into account that at around pH 7n5 the enzymic and the non-enzymic reactions of FAD were very sensitive to pH (see Figure 2E ), it must be emphasized that the buffers were adjusted to within p0n01 pH units of the desired value at 37 mC, and that all the controls and blanks were run strictly in parallel with enzymecontaining samples, using the same batches of buffers and other reagents. One unit of activity is defined as 1 µmol of substrate split (P i formed ; see reaction 1 below)\min at 37 mC.
Specific
Phosphodiesterase activity on 4h,5h-cFMN, 3h,5h-cAMP or 2h,3h-cAMP, and FMN phosphomonoesterase activity were assayed by a P i -release method like that for FMN cyclase except that 0n5 mM substrate was used, 2n5 mM MgCl # was substituted for MnCl # and, when FMN was the substrate, alkaline phosphatase was omitted. The possible formation of 3h,5h-cAMP or 3h,5h-cGMP was assayed as for FMN cyclase activity except that 0n4 mM ATP or GTP was substituted for FAD, alkaline phosphatase was omitted and samples were analysed by HPLC method 3 (see below), which resolved 3h,5h-cAMP (3h,5h-cGMP) from adenosine (guanosine) phosphates. The possible formation of FAD from FMN and ATP was assayed as for both FMN cyclase (except that 0n5 mM FMN and 0n5 mM ATP were substituted for FAD and alkaline phosphatase was omitted) and rat liver FAD synthetase [7, 8] , measuring FAD formation by HPLC method 1 in both cases.
Preparation of enzymically formed cFMN
cFMN was purified from reaction mixtures with 1n2 mM FAD, 6 mM MnCl # and 25 m-units\ml FMN cyclase, in 80 % (v\v) buffer T with 150 mM KCl. After 70 min at 37 mC, 0n5 ml samples were chromatographed on a Prep Nova-Pak HR C ") column (30 cmi0n78 cm ; Waters) with a Hypersil ODS precolumn (20 mmi2n1 cm), at 1 ml\min, in 45 mM ammonium formate, pH 6n4, in 19 % (v\v) methanol. cFMN was eluted (30 min) separated from FAD and AMP. Control mixtures like those used for synthesis, except that enzyme was omitted, were incubated and chromatographed under the same conditions, to check for non-enzymic FAD conversion into cFMN and AMP. These controls indicated that in fact less than 10 % of the cFMN produced in the presence of enzyme was produced nonenzymically, i.e. more than 90 % of total cFMN was synthesized by FMN cyclase. The pooled cFMN peaks from five to ten runs were repeatedly lyophilized to remove the eluent. The final molar recovery of cFMN was around 50 % of FAD. Its purity was more than 99 % by HPLC (method 1 with A #&! detection as in Figures 3A-3F) . "H-NMR spectra showed, at δ 3n5 p.p.m. (Fig- ure 5B), a minor contaminant, without any corresponding signal in the "$C-NMR spectrum.
Analytical HPLC
A Hypersil ODS column (150 mmi3n9 mm) and precolumn (20 mmi2n1 mm) and a Hewlett-Packard HP-1090 chromatograph were used. Samples of 20-50 µl, diluted as needed, were injected and eluted at 0n5 ml\min with a binary system dispensing two buffers. For method 1 the conditions were as follows : buffer A, 10 mM sodium phosphate, pH 7 ; buffer B, 10 mM sodium phosphate, pH 7, 50 % (v\v) methanol ; elution, 0-5 min, isocratic 100 % A, 5-5n5 min, linear gradient up to 70 % A and 30 % B, 5n5-16 min, isocratic 70 % A and 30 % B, 16-16n5 min, linear gradient up to 50 % A and 50 % B, after 16n5 min, isocratic 50 % A and 50 % B. For method 2 conditions were : buffer C, 5 mM sodium phosphate, pH 7, 20 % (v\v) methanol, 10 mM sodium tetrabutylammonium ; buffer D, same as C with 100 mM phosphate ; elution, linear gradient from 100 % C to 100 % D in 20 min. For method 3 conditions were : buffers C and D as in method 2 ; elution, linear gradient from 100 % C to 40% C and 60 % D in 10 min, and then to 100 % D in another 10 min. For method 4 conditions were : isocratic elution with 30 % buffer A and 70 % buffer B.
RESULTS AND DISCUSSION
Non-enzymic splitting of FAD
It is known that Mn# + catalyses the non-enzymic hydrolysis of FAD [20] and, in alkaline solutions, FAD decomposes giving
Figure 2 Properties of FMN cyclase activity
Initial rates were assayed by measuring either the liberation of P i (A 820 ) in 0n4 ml reaction mixtures ($) or the hyperchromicity (A 265 ) of FAD splitting in 1n2 ml reaction mixtures (#). All the enzymic initial rates are corrected for non-enzymic FAD splitting. Some non-enzymic reaction rates are also shown (W) as well as some raw A 820 values (, , , ). [23] to rates up to 62 µM FAD. This gave a K m of 6n0p0n8 µM (S.E. for the adjustment [23] ). The inset shows a linear transformation of the same data (=) and hyperbola. Another experiment gave similar results (K m 7n2p1n3 µM). For the sake of clarity, no-enzyme controls are not shown in this part ; below 40 µM FAD they gave negligible rates ( 5 % of enzyme activity). (D, E) Mn 2 + requirement for activity and pH-activity profile (assayed with 5 and 2n5 m-units of FMN cyclase respectively). The rates are meansprange for two experiments. (F) Native M r by gel filtration in a Sephadex G-150 column (87n5 cmi1n2 cm) in buffer T and 100 mM KCl. The inset shows the calibration plot obtained with protein markers (5) : amylase (200 000), aldolase (158 000), BSA (66 000), egg albumin (45 000), chymotrypsinogen (25 000) and cytochrome c (12 400).
4h,5h-cFMN [21, 22] . Throughout this work, to ensure that the results represented true enzyme activity, the non-enzymic splitting of FAD was systematically controlled by running every individual enzyme assay mixture in parallel with a non-enzyme counterpart. The rate of non-enzymic FAD splitting increased linearly with FAD or Mn# + concentration (at least up to 1 mM FAD and 10 mM MnCl # ; results not shown and Figure 2D respectively), and depended on pH as shown in Figure 2 (E). Under the conditions of the standard FMN cyclase assay (1n2 mM FAD, 6 mM MnCl # and pH 7n5, at 37 mC), the non-enzymic rate was about 1n5 nmol\min per ml of reaction mixture, which allowed the reliable measurement of enzyme rates of similar magnitude after discounting the non-enzymic reaction. For instance, Figure  2 (A) shows the time-linear increments of crude A )#! values corresponding to FAD splitting in reaction mixtures that contained enzyme catalysing the reaction at 1-, 2-and 3-fold the non-enzymic rate. Furthermore, it should be emphasized that many experiments were performed at much higher ratios of enzyme\non-enzyme reaction, either by working at higher enzyme and\or at lower FAD and Mn# + concentrations than in Figure 2 (A). Particular examples are pointed out below.
Enzymic characterization of the FAD-splitting activity
The FAD-splitting activity was studied with an alkaline phosphatase-coupled P i -release assay or, when FAD concentrations lower than 50 µM were used ( Figure 2C) , with a spectrophotometric assay that measured the UV hyperchromicity due to FAD splitting. These two assays yielded similar initial rates (see Figure 2C at 40-50 µM FAD). In addition, the rate of P i liberation was equal to the rate of conversion of FAD into reaction products, measured by HPLC. This was validated under initial rate conditions by sampling standard reaction mixtures simultaneously for colorimetric assay of P i and for assay of cFMN formation by HPLC method 4. That the splitting of 1 mol of FAD gave equimolar cFMN and alkaline phosphatasereleasable P i was also confirmed after exhaustion of FAD by incubation with FMN cyclase (see the next section).
The basic kinetic and molecular properties shown below demonstrated clearly the enzymic character of the FAD-splitting activity after discounting and in contrast with the non-enzymic process described in the preceding section. First of all, enzymic FAD splitting was inactivated by heating, whereas the rate of FAD splitting measured in the presence of heat-inactivated enzyme equalled that measured in no-enzyme controls ( Figure  2B ).
The enzyme-dependent activity displayed hyperbolic kinetics in the range 0-60 µM substrate, with a K m of 6-8 µM for FAD, whereas FAD at concentrations higher than 100 µM was inhibitory ( Figure 2C ). In this experiment, below 40 µM FAD, non-enzymic splitting was undetectable ( 5 % of enzymic reaction, i.e. the enzyme to non-enzyme rate ratio was 20) whereas at higher concentration it increased linearly with FAD (not shown).
The enzymic activity required Mn# + , not Mg# + , and displayed saturation kinetics for Mn# + in the range 0-10 mM MnCl # , with an apparent K m of 1n3 mM ( Figure 2D ). In this experiment, carried out at pH 7n5 and with 1n2 mM FAD, the enzyme\non-enzyme rate ratio was 7 at 6 mM MnCl # , i.e. considerably higher than in Figure 2(A) , because of the higher enzyme concentration used. At less than 6 mM MnCl # , the ratio was even higher (e.g. 27 at 1 mM MnCl # ) because the enzyme and non-enzyme reactions responded differently to lowering MnCl # concentrations : they showed saturation and non-saturation kinetics respectively ( Figure 2D) .
The pH profile of the enzymic splitting of FAD resembled that of the non-enzymic reaction with a broad pH optimum around 9 ( Figure 2E) ; this coincidence points to the two reactions sharing some mechanistic feature. However, the two profiles were not exactly equivalent : the ratio of enzyme to non-enzyme FAD splitting decreased with increasing pH, from 2n8 at pH 7n4-7n6 to 1n5 at pH 8n5-10.
The native M r of the protein responsible for the enzymic splitting of FAD was estimated from the elution profile of the activity in a gel-filtration experiment. The results indicate an apparent M r of approx. 140 000 ( Figure 2F) .
Products of the FAD-splitting activity
The reaction products of the enzymic splitting of FAD were detected by HPLC in standard reaction mixtures (see the Materials and methods section), except that FAD concentration was 0n4 mM and alkaline phosphatase was omitted. A high concentration of FMN cyclase was used to ensure a high yield of products and a high ratio of enzyme to non-enzyme reaction. The incubation was prolonged until the completion of FAD splitting. Under these conditions, FAD was completely converted into two UV-absorbing products. In the chromatographic system [24] . Shorter incubations (not shown) indicated that 3h-FMN started to form only after 4h-FMN had accumulated. (N) Impure 5h-FMN (76 % ; Sigma cat. no. F-2253) dissolved in water. The major contaminants of impure 5h-FMN preparations are reported to be 4h-FMN and, less abundantly, 3h-FMN [24] [25] [26] . The arrows mark retention times of standards, except cFMN, the FMN cyclase product. The identities of all the standards were confirmed by injecting them one at a time. The unlabelled peak in (A), with a retention time of 9 min, which actually appeared in all HPLC method-1 chromatograms (A-F, I-N) , was an artifact related to the programmed entry of methanol in the column a few minutes in advance. Its prominence in (A), relative to the other chromatograms, was due to the use of a larger-scale expansion.
of Figures 3A-3F (HPLC method 1) , they eluted with retention times of about 3n8 min and 22 min (Figures 3C and 3D ). Since the one eluted first was not detectable at 430 nm, whereas the second one clearly was (in fact the 22 min peak collected was deep yellow), it was concluded that they contained the adenine and isoalloxazine moieties of FAD respectively. Non-enzymic FAD splitting yielded the same product pattern but at much lower rate (compare Figures 3D and 3F) , such that more than 90 % of reaction products in Figure 3 (D) were of enzymic origin. All the following evidence demonstrates that the products were AMP and cyclic FMN (cFMN).
Figure 4 4h,5h-cFMN, the chemical structure of the cyclic nucleotide formed by rat liver FMN cyclase
By HPLC method 1 ( Figures 3A-3F) , adenosine was discounted as one of the products because of its retention time of about 12 min. However, in this system, AMP and ADP were barely retained (retention times 3-4 min), tended to overlap and it was difficult to discount either of them as being identical with the 3n8 min peak product of FMN cyclase. To distinguish unambiguously between AMP and ADP, the peak with a retention time of 3n8 min in Figure 3 (D) was collected and rechromatographed in a different system (HPLC method 2) in which adenosine phosphates were retained and resolved, and which allowed the clear identification of the enzyme product as AMP ( Figure 3G ). This was confirmed by product co-elution with authentic AMP, and by its conversion by AMP deaminase into another compound which was co-eluted with IMP by HPLC method 2 (not shown). To discount the possibility that the 3n8 min peak of Figure 3 (D) could have corresponded (in part) to ADP but was not seen in the chromatogram of Figure 3 (G) because of degradation to AMP, a control experiment was carried out in which ADP was added to the FMN cyclase mixture at the end of the incubation period. After collection of the material eluted at 3-5 min by HPLC method 1, and rechromatographing it by method 2, 100 % of the ADP added was recovered with the expected retention time, well separated from AMP ( Figure 3H ).
By HPLC method 1, the yellow product of the FAD splitting, with a retention time of 22 min, was clearly different from FMN and riboflavin ( Figures 3C and 3D) .
When the enzymic splitting of FAD was carried out in the presence of alkaline phosphatase, as in the standard P i -release assay, HPLC results showed the formation of adenosine (not AMP) and the same yellow product ( Figure 3E) , and 1 mol of P i \mol of FAD split was detected colorimetrically (not shown). In contrast with the product pattern of FMN cyclase, FAD pyrophosphatases such as snake venom phosphodiesterase and rat liver nucleotide pyrophosphatase, after incubation in mixtures with the standard composition and conditions of FMN cyclase assays (see the Materials and methods section and Figure 3D ), converted FAD into FMN and AMP in the absence of alkaline phosphatase or, after phosphatase treatment, into riboflavin and adenosine ; in this case, 2 mol of P i \mol of FAD split was measured.
An important conclusion of the above experiments was that FMN cyclase split FAD leaving one phosphatase-resistant phosphate bound to riboflavin, an indication that the unknown product was a cFMN. That it actually contained phosphate (1 mol\mol) was supported by comparisons of the "H-and "$C-NMR spectra of cFMN and FMN, and it was directly demonstrated on use of cFMN as a substrate for a cyclic nucleotide phosphodiesterase activity, also identified in rat liver, which was assayed by coupling it to alkaline phosphatase and colorimetric determination of P i (see below).
Structural characterization of the riboflavin-containing product as 4h,5h-cFMN
The unknown product of FAD splitting that behaved as cFMN was purified by HPLC from reaction mixtures in which nonenzymic FAD splitting represented less than 10 % of the enzymic reaction. The purified product was identified as 4h,5h-cFMN (Figure 4 ) by UV-visible and NMR spectroscopy ( Figure 5) , and by HPLC analyses of the products of acid hydrolysis ( Figures  3I-3N) .
The UV-visible spectrum of cFMN at neutral pH was like that of FMN and riboflavin, demonstrating the presence of oxidized isoalloxazine ( Figure 5A) .
The "H-and "$C-NMR spectra of cFMN (Figures 5B and 5C) were clearly related to FMN and riboflavin ( Table 2 , [27] [28] [29] ) ; the resonances of their respective 7,8-dimethylisoalloxazine moieties showed no major differences. However, full assignment of the ribityl chain of cFMN required more informative, "H-"H ( Figure  5E ) and "$C-"H ( Figure 5F ) correlated spectra. Selective irradiations of protons (not shown) were also carried out and, for proton couplings, led to the same conclusions as the "H-"H correlated spectrum. From these data, the assignment of the ribityl signals of cFMN can be explained as follows. Figure 5F ). (e) The other part of the signal at 4n1 p.p.m. corresponds to H2h, as it is coupled to H1h a ( Figure 5E ) but linked to one carbon different from C1h ( Figure 5F ) which, at the same time, can be then identified as C2h (δ 69n4 p.p.m.). (f) The signal at 4n5 p.p.m. corresponds to H4h and H1h b , as it is coupled to H5h a , H5h b \H2h and H1h a ( Figure 5E ). (g) The signal at 3n9 p.p.m. must then correspond to H3h, and it shows the expected couplings with the H2h and H4h signals ( Figure 5E ). (h) The signal at δ 72n6 p.p.m. can be assigned to C3h by its linkage to H3h ( Figure 5F ) and, finally, that at δ 75n3 p.p.m. to C4h.
The above assignment of cFMN nuclei did not by itself allow us to ascertain which of the ribityl carbons were linked to phosphate. However, this question was answered by comparison of cFMN with FMN. The differences between the cFMN and FMN spectra (Table 2) other carbons, C5h showed a slight (0n8 p.p.m.) and C4h a strong (4n1 p.p.m.) downfield shift in cFMN relative to FMN. The same can be said of H5h ab and H4h which were shifted downfield by 0n2-0n5 p.p.m. and 0n6-0n7 p.p.m. The stronger downfield shifts of C4h and H4h were in agreement with their expected unshielding on phosphate esterification of the 4h-OH group. That C3h resonated as a broad singlet in cFMN can then be explained by a small three-bond P-O-C4h-C3h coupling. That 5h-OH is also esterified by phosphate in cFMN, as it is in FMN, was indicated because otherwise one would expect stronger shielding, and therefore upfield shifts, of C5h and H5h ab in cFMN relative to FMN. That the chemical shifts for C5h and H5h ab were more affected than those for C3h and H3h by the esterification of the 4h-OH by phosphate may be because in 4h,5h-cFMN the 5h position is part of the cycle whereas 3h is not. Finally, the absence or insignificance of phosphorus coupling to C4h and C5h of cFMN, which resonated as singlets in contrast with the doublets shown by these nuclei in FMN, is probably related to the conformation of the phosphate-cyclized ribityl chain of cFMN compared with the open ribityl chain in FMN, since conformation is known to determine "$C-$"P coupling in other cyclic nucleotides [30, 31] .
The identification of cFMN as 4h,5h-cFMN was confirmed by acid treatment and HPLC analyses (Figures 3I-3N) . cFMN was easily and completely converted into two products ( Figures  3H-3J ), one at 18 min, coincident with 5h-FMN, and the other at 17 min, identified as 4h-FMN by its coincidence with (i) the first detectable product of the slow phosphate migration elicited by acid treatment of 5h-FMN ( Figure 3L and shorter incubations not shown) [24, 25] and (ii) the major contaminant of impure 5h-FMN preparations ( Figure 3M ) [24] [25] [26] .
Specificity of the FAD-splitting activity
4h,5h-cFMN was not a by-product or a stable catalytic intermediate of the hydrolysis of FAD by an FAD pyrophosphatase. FAD was converted stoichiometrically into 4h,5h-cFMN without riboflavin phosphomonoester formation, and 4h,5h-cFMN itself, tested as a substrate instead of FAD under the standard assay conditions for FMN cyclase (with 6 mM MnCl # ; see the Materials and methods section), was not attacked by the enzyme preparation that formed it. Thus the enzyme reaction is FAD AMPj4h,5h-cFMN
This specificity is not recorded by the Enzyme Commission nor has it been reported previously. The partially purified enzyme did not split NAD + , NADH or diadenosine 5h,5e-diphosphate, nor did it show any adenylate cyclase, guanylate cylase or FAD synthetase activity (each 1 %, except NAD + splitting, which was 3 % of FAD-splitting activity). Therefore a novel enzyme which should be named FAD-AMP lyase (cyclizing) or FMN cyclase may exist in rat liver.
This enzyme was inactive in the absence of added bivalent cations, although it should be stressed that the extraction and purification were carried out in 0n5 mM EDTA. The EDTAcontaining cyclase, assayed with 1n2 mM FAD, was activated by millimolar concentrations MnCl # but not MgCl # . Since the total and free Mn# + content of rat liver are estimated to be lower than 50 µM and 1 µM respectively [32, 33] , it seems that either Mn# + is not the physiological activator of the enzyme or optimal conditions for (re)activation have not yet been found. Further explorations of the bivalent cation specificity or attempts to purify the FMN cyclase activity from EDTA-free extracts have not been performed.
Hydrolysis of 4h,5h-cFMN by a cyclic phosphodiesterase of rat liver
4h,5h-cFMN was resistant to rat liver nucleotide pyrophosphatase and snake venom phosphodiesterase, but it was hydrolysed by a cyclic nucleotide phosphodiesterase separated from FMN cyclase in the gel-filtration step of Figure 1(A) . The phosphodiesterase was adsorbed on a DEAE-cellulose column in 20 mM Tris\HCl, pH 7n5, and eluted with a 200 ml KCl gradient (0-600 mM) in buffer T, as a peak centred around 300 mM KCl (not shown). It was probably active with other cyclic nucleotides, as in the DEAE-cellulose column it was co-eluted with phosphodiesterase activity on 3h,5h-cAMP and 2h,3h-cAMP (about 25 and 50 % of the activity with 4h,5h-cFMN). The products of 4h,5h-cFMN hydrolysis were 5h-FMN and riboflavin (HPLC results not shown), indicating hydrolysis to 5h-FMN and the presence of a contaminating FMN phosphomonoesterase, the activity of which was also detected using FMN as the substrate.
A novel enzymic pathway for flavins and potential roles for 4h,5h-cFMN
So far, 4h,5h-cFMN has been known only as a non-enzymic product of FAD in alkaline solutions [21, 22] and a contaminant in commercial FAD [25] . In biological systems, there is no antecedent for 4h,5h-cFMN other than 2h,5h-cFMN, which occurs in Rhizopus molds and displays some cytocidal activity on tumour cells [34, 35] . 2h,5h-cFMN is formed from riboflavin by a GTP-dependent synthetase of Rhizopus [36, 37] , a specificity different from reaction (1) . Thus this work suggests a novel enzymic pathway for flavins in mammals :
The two enzyme activities involved, cyclase and phosphodiesterase, have been identified in the cytosolic fraction of rat liver homogenates, but other cellular locations cannot be ruled out, as the activities were not assayed in the particulate fraction. The very existence of FMN cyclase, its specificity and low K m near the intracellular free concentration of the substrate [6] demonstrate the biological relevance of 4h,5h-cFMN, which is perhaps formed in i o at low concentrations that so far have escaped detection.
Elucidation of the biological role(s) of 4h,5h-cFMN will require further investigation, but two possibilities should be mentioned here. One is that it may be a redox flavocoenzyme. The second, revealed by comparison with other well-known cyclic nucleotides (cAMP, GMP, cADP-ribose [38, 39] ) also produced from coenzymes (ATP, GTP and NAD + ) [40] [41] [42] , is that 4h,5h-cFMN may have a role in cell regulation as a signal molecule.
